Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
14.37
+0.05 (0.35%)
At close: Mar 9, 2026, 4:00 PM EDT
14.37
0.00 (0.00%)
After-hours: Mar 9, 2026, 6:55 PM EDT
Aurinia Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,911 | 2,103 | 1,286 | 1,291 | 614 | 2,966 | |
| Market Cap Growth | 70.44% | 63.55% | -0.41% | 110.30% | -79.30% | 69.42% | |
| Enterprise Value | 1,588 | 1,830 | 1,025 | 1,047 | 246 | 2,688 | |
| Last Close Price | 14.37 | 15.95 | 8.98 | 8.99 | 4.32 | 22.87 | |
| PE Ratio | 6.94 | 7.32 | 223.53 | - | - | - | |
| Forward PE | 17.67 | 19.69 | 24.06 | - | - | - | |
| PS Ratio | 6.75 | 7.43 | 5.47 | 7.36 | 4.58 | 65.03 | |
| PB Ratio | 3.27 | 3.62 | 3.41 | 3.42 | 1.51 | 6.19 | |
| P/TBV Ratio | 3.31 | 3.64 | 3.45 | 3.46 | 1.54 | 6.30 | |
| P/FCF Ratio | 14.11 | 15.53 | 29.15 | - | - | - | |
| P/OCF Ratio | 14.09 | 15.50 | 28.97 | - | - | - | |
| EV/Sales Ratio | 5.61 | 6.46 | 4.36 | 5.97 | 1.84 | 58.94 | |
| EV/EBITDA Ratio | 11.70 | 13.48 | 32.08 | - | - | - | |
| EV/EBIT Ratio | 13.66 | 15.74 | 81.91 | - | - | - | |
| EV/FCF Ratio | 11.73 | 13.51 | 23.25 | - | - | - | |
| Debt / Equity Ratio | 0.13 | 0.13 | 0.21 | 0.26 | 0.02 | 0.02 | |
| Debt / EBITDA Ratio | 0.55 | 0.55 | 2.42 | - | - | - | |
| Debt / FCF Ratio | 0.55 | 0.55 | 1.80 | - | - | - | |
| Net Debt / Equity Ratio | -0.56 | -0.56 | -0.74 | -0.67 | -0.94 | -0.95 | |
| Net Debt / EBITDA Ratio | -2.38 | -2.38 | -8.73 | 3.41 | 3.51 | 2.57 | |
| Net Debt / FCF Ratio | -2.39 | -2.39 | -6.33 | 7.40 | 4.78 | 2.89 | |
| Asset Turnover | 0.44 | 0.44 | 0.43 | 0.35 | 0.26 | 0.09 | |
| Inventory Turnover | 1.54 | 1.54 | 1.24 | 1.98 | 2.30 | 3.14 | |
| Quick Ratio | 4.70 | 4.70 | 4.05 | 4.86 | 8.76 | 11.84 | |
| Current Ratio | 5.25 | 5.25 | 4.57 | 5.50 | 9.60 | 12.63 | |
| Return on Equity (ROE) | 59.91% | 59.91% | 1.52% | -19.92% | -24.46% | -40.81% | |
| Return on Assets (ROA) | 11.16% | 11.16% | 1.42% | -10.53% | -13.74% | -22.43% | |
| Return on Invested Capital (ROIC) | 66.31% | 65.20% | 8.65% | -114.84% | -482.28% | -907.37% | |
| Return on Capital Employed (ROCE) | 17.70% | 17.70% | 2.80% | -18.20% | -26.20% | -36.00% | |
| Earnings Yield | 15.03% | 13.66% | 0.45% | -6.04% | -17.62% | -6.10% | |
| FCF Yield | 7.09% | 6.44% | 3.43% | -2.65% | -13.00% | -5.33% | |
| Buyback Yield / Dilution | 5.13% | 5.13% | -2.07% | -0.93% | -9.70% | -9.20% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.